Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA commissioner with experience akin to drug advisory cmte. chair suggested by NDMA.

This article was originally published in The Tan Sheet

Executive Summary

FDA COMMISSIONER SEARCH: DRUG ADVISORY CMTE. CHAIR EXPERIENCE cited by the Nonprescription Drug Manufacturers Association as a desirable qualification for the future FDA head. In a Feb. 4 letter to HHS Secretary Donna Shalala, NDMA recommends that the new commissioner have "a recognized expertise in managing sensitive medical and scientific issues, as might be found in a person who had served as chairman to a drug advisory committee." Among the names that have been circulated as a possible successor to retiring FDA Commissioner David Kessler, MD, is former Nonprescription Drugs Advisory Committee Chair Randy Juhl, PhD, dean of the University of Pittsburgh School of Pharmacy ("The Tan Sheet" Dec. 9, 1996, p. 11).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel